PET/MRI scanning for advanced nasopharyngeal cancer staging
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial uses a special combined PET and MRI scan to get a detailed picture of advanced nasopharyngeal cancer before starting treatment. The goal is to see how well this imaging method helps doctors plan the best care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of nasopharyngeal carcinoma (a type of cancer in the throat behind the nose).
- Your cancer must be locally advanced — stage 3 or 4, meaning it has spread to nearby tissues or lymph nodes (T3/T4, N2/N3).
- You must be 18 years or older.
- You must be able to give signed consent, understanding the study and its risks.
- You must not have poorly controlled diabetes.
- You must not have had prior head/neck cancer, or any other cancer that hasn't been cured for at least 3 years.
- You must be able to safely undergo PET/MRI scans — no metal implants, MRI contraindications, or contrast dye allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system responds to radiation therapy for nasopharyngeal cancer. It will use scans and blood tests to find markers that might predict how well treatment works.
This trial tests a special PET scan that can detect a receptor (SSTR2) on cancer cells to see if it can help guide treatment for people with nasopharyngeal cancer (a type of head and neck cancer). It may help doctors choose the best therapy for you.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
This study uses special MRI images (and computer “radiomics” scores) to better understand nasopharyngeal cancer. The goal is to help doctors choose the most appropriate treatment for people with newly diagnosed cancer.
This trial tests a more precise form of radiation therapy (adaptive radiotherapy) for nasopharyngeal cancer. It is designed for patients who have not yet had any treatment and whose cancer is limited to the head and neck area.
This trial tests whether combining a special scope (NBI) with MRI scans can help doctors better target radiation therapy for a specific type of nose/throat cancer that affects only one side. It aims to make treatment more precise and reduce side effects.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.